Maintal, Germany

Bjoern Hock

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Maintal-Doernigheim, DE (2018)
  • Maintal, DE (2006 - 2023)

Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Innovations of Bjoern Hock: Pioneering Monoclonal Antibodies

Introduction

Bjoern Hock, an esteemed inventor based in Maintal, Germany, has made significant contributions to the field of biotechnology with a remarkable portfolio of 15 patents. His work primarily focuses on monoclonal antibodies and innovative methods for treating various pathological conditions, making him a prominent figure in the medical research community.

Latest Patents

Among his latest patents, Bjoern Hock has developed a groundbreaking monoclonal antibody directed to FGFR1. This invention details antibodies that exhibit high affinity towards human, macaque, and mouse forms of FGFR1, providing potential applications in cancer diagnosis and treatment. Additionally, he has conceptualized a method for generating bispecific shark variable antibody domains (vNAR domains), which includes fusion proteins and polynucleotide libraries meant for the treatment of pathological conditions. The comprehensive approach of his patents highlights their usefulness in therapeutic settings.

Career Highlights

Bjoern Hock has had a noteworthy career, contributing his expertise to esteemed organizations such as Merck Patent GmbH and Ablynx N.V. His roles in these companies have significantly enhanced their research capabilities, particularly in the development of advanced biopharmaceuticals. His continuous commitment to innovation has established him as a forward-thinking inventor in the field.

Collaborations

Throughout his career, Bjoern has worked alongside talented colleagues, including Stefan Becker and Ralf Guenther. These collaborations have fostered a collaborative environment conducive to groundbreaking research and development, allowing for shared expertise and knowledge that drives innovation further.

Conclusion

Bjoern Hock's contributions to biotechnology, particularly in the realm of monoclonal antibodies, showcase his inventive spirit and commitment to advancing medical research. With a robust patent portfolio and impactful collaborations, he is poised to continue influencing the future of biopharmaceutical innovations. His work not only highlights the pivotal role of inventors in research institutions but also emphasizes the importance of collaboration in driving scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…